Opendata, web and dolomites

PATHOLYTIX-GI

PATHOLYTIX: Using Artificial Intelligence to Transform Clinical Diagnostic Pathology

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PATHOLYTIX-GI project word cloud

Explore the words cloud of the PATHOLYTIX-GI project. It provides you a very rough idea of what is the project "PATHOLYTIX-GI" about.

effect    medical    trained    pathological    components    direct    decreasing    ltd    extensive    cad    reducing    millions    laborious    transforming    expert    population    patients    techniques    worldwide    individual    workflow    reduce    performed    soaring    innovative    deciphex    costly    patholytix    streamline    efficient    tissue    pathologist    centuries    data    irish    framework    pathology    automate    revolutionize    preliminary    alleviate    becomes    purpose    faces    knock    microscope    types    regards    markets    instrument    perform    leader    company    uses    industry    intelligence    undergo    validation    big    hence    coupled    global    pilot    competitors    fit    cancer    routine    competition    biopsies    prototype    crises    tissues    solution    tool    clinics    hundreds    diseases    hospitals    aided    computer    productivity    prevalence    market    artificial    sme    additional    cell    pathologists    clinical    interface    diagnosis    feasibility   

Project "PATHOLYTIX-GI" data sheet

The following table provides information about the project.

Coordinator
DECIPHEX LIMITED 

Organization address
address: 7 GARRAI NA GCRANN
city: MORNINGTON MEATH
postcode: n.a.
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Project website http://www.deciphex.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-12-01   to  2018-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DECIPHEX LIMITED IE (MORNINGTON MEATH) coordinator 50˙000.00

Map

 Project objective

Routine diagnosis on biopsies and tissues is performed by expert pathologists. However, the pathology sector faces a major crises, due to soaring numbers of biopsies for diagnosis, coupled with decreasing numbers of trained pathologists, which is affecting patients. Technology can alleviate this crises by using computer aided diagnosis (CAD) to increase productivity, reduce costs and streamline workflow.

Deciphex Ltd is an Irish company developing an innovative Computer Aided Diagnosis (CAD) system which will revolutionize the medical diagnosis pathology sector. Our ‘PATHOLYTIX’ system uses state-of-the-art artificial intelligence techniques to automate the laborious and costly pathology assessment (currently done via microscope). By transforming this centuries old clinical practice, we aim to become a market leader in new CAD industry.

We currently have prototype technology and preliminary data, to identify different tissue and cell types. In this feasibility study we will perform pilot studies in a US based clinical pathologist, to demonstrate our tool can identify various diseases. In Phase 2 of the SME Instrument, we will undergo additional development, extensive validation, and build the data management framework and user interface.

There is a large global target market for PATHOLYTIX, which is growing each year driven by an increasing population and higher prevalence of diseases (such as cancer). Hence hospitals and clinics worldwide process hundreds of millions of biopsies per year. With regards to competitors, there is no direct competition. Competitors offer individual components of the pathological workflow, not fit-for-purpose solution like PATHOLYTIX.

Overall, PATHOLYTIX would have a big impact on the pathology sector, by increasing productivity and reducing costs. This should have a knock on effect for the global and EU markets, particularly for patients as diagnosis becomes more efficient.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PATHOLYTIX-GI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PATHOLYTIX-GI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More  

ImmuneHunter (2017)

Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously

Read More